Cellosaurus STBCi322-A-1 (CVCL_C1XW)
Cell line name | STBCi322-A-1 |
---|---|
Synonyms | NKX6.1-GFP reporter line; NKX6.1-GFP clone 1a-10-3; AZi323-A-1 |
Accession | CVCL_C1XW |
Resource Identification Initiative | To cite this cell line use: STBCi322-A-1 (RRID:CVCL_C1XW) |
Comments | From: AstraZeneca; Cambridge; United Kingdom. Characteristics: Using CRISPR/Cas9 a T2A-GFP-LoxP-PGKp-Neo-LoxP construct was introduced at the C-terminus of NKX6-1. Subsequently the LoxP-PGKp-Neo-LoxP sequence was removed by Cre-mediated excision (PubMed=29734117). Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Transposon Tn5 neo. Derived from site: In situ; Skin; UBERON=UBERON_0002097. Cell type: Fibroblast of skin; CL=CL_0002620. |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_ZX55 (STBCi322-A) |
Sex of cell | Female |
Age at sampling | 36Y |
Category | Induced pluripotent stem cell |
Publications | PubMed=29734117; DOI=10.1016/j.scr.2018.04.010 |
Cross-references | |
Cell line databases/resources | hPSCreg; STBCi322-A-1 |
Encyclopedic resources | Wikidata; Q114313049 |
Entry history | |
Entry creation | 22-Sep-2022 |
Last entry update | 10-Sep-2024 |
Version number | 5 |